Skip to content
2000
Volume 19, Issue 2
  • ISSN: 1872-2105
  • E-ISSN: 2212-4020

There is no abstract available.

Loading

Article metrics loading...

/content/journals/nanotec/10.2174/0118722105254232230920053519
2023-10-11
2025-06-24
Loading full text...

Full text loading...

/deliver/fulltext/nanotec/19/2/NANOTEC-19-2-01.html?itemId=/content/journals/nanotec/10.2174/0118722105254232230920053519&mimeType=html&fmt=ahah

References

  1. BabaieS. BakhshayeshA.R.D. HaJ.W. HamishehkarH. KimK.H. Invasome: A novel nanocarrier for transdermal drug delivery.Nanomaterials (Basel).2020102341
    [Google Scholar]
  2. JainS. TripathiS. TripathiP.K. Invasomes: Potential vesicular systems for transdermal delivery of drug molecules.J. Drug Del. Sci. Tech.202161102166
    [Google Scholar]
  3. ShankarR. UpadhyayP.K. KumarM. Invasomes for enhanced delivery through the skin: Evaluation of systems to meet with clinical challenges.Pharm. Nanotechnol.202195317325
    [Google Scholar]
  4. PandeyS. SrivastavaV. An overview on invasomes: Novel vesicular carrier for transdermal drug delivery.Res. J. Topical. Cosmetic. Sci.2021122107112
    [Google Scholar]
  5. ChackoI.A. GhateV.M. DsouzaL. LewisS.A. Lipid vesicles: A versatile drug delivery platform for dermal and transdermal applications.Colloids and Surfaces B: Biointerfaces2020195111262
    [Google Scholar]
  6. VidyaK. LakshmiP.K. Cytotoxic effect of transdermal invasomalanastrozole gel on MCF-7 breast cancer cell line.J. Applied. Pharm. Sci.2019935058
    [Google Scholar]
  7. BhardwajP. DilbaghiN. Pharmaceutical nanoarchitectonics: Molecular pharmaceutics and smart delivery of β-caryophyllene constellated 5-FU nanoinvasomes for skin cancer therapy.BioNanoScience20222712
    [Google Scholar]
  8. SalemH.F. GamalA. SaeedH. KamalM. TulbahA.S. Enhancing the bioavailability and efficacy of vismodegib for the control of skin cancer: In vitro and in vivo studies.Pharmaceuticals (Basel)2022152126
    [Google Scholar]
/content/journals/nanotec/10.2174/0118722105254232230920053519
Loading

  • Article Type:
    Editorial
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test